The Claim
Oral administration of BLS-M22 for 12 weeks in aged mdx mice with advanced Duchenne muscular dystrophy is associated with improved rotarod endurance at 10 rpm, without significant changes in muscle fiber size or fibrosis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In aged mice with a severe form of muscular dystrophy, a 12-week course of oral BLS-M22 was linked to better performance on a rotating rod test at 10 rpm, without altering muscle fiber size or scar tissue levels.
See the scientific wording
In aged mdx mice with advanced Duchenne muscular dystrophy, oral BLS-M22 treatment is associated with improved rotarod endurance at 10 rpm after 12 weeks, indicating enhanced motor coordination, despite no significant change in muscle fiber size or fibrosis.
A special probiotic delivers a piece of the myostatin protein through the gut, which trains the immune system to make antibodies that lock onto and disable myostatin in the blood. Without myostatin blocking muscle repair, the muscle membrane becomes less fragile, so fewer muscle proteins leak out and the muscles can work longer without failing.
What the research says
1 studyIn old mice with severe muscle disease, a special probiotic drink helped them stay on a spinning rod longer, even though their muscles didn’t get bigger or heal scar tissue. So the probiotic improved their movement without fixing the muscle damage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.